Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
306 studies found for:    autism spectrum disorders OR autism OR pervasive developmental disorders OR PDD OR Kanner's syndrome OR child mental disorders OR asperger syndrome OR autistic OR developmental disabilities | Open Studies | Exclude Unknown | NIH
Show Display Options
RSS Create an RSS feed from your search for:
autism spectrum disorders OR autism OR pervasive developmental disorders OR PDD OR Kanner's syndrome OR child mental disorders OR asperger syndrome OR autistic OR developmental disabilities | Open Studies | Exclude Unknown | NIH
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Screening for Studies on Autism Spectrum Disorders
Condition: Autism Spectrum Disorders
Intervention:
2 Recruiting Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Condition: Autism
Interventions: Behavioral: JASP-EMT;   Behavioral: DTT
3 Recruiting Cognitive Neuroscience of Autism Spectrum Disorders
Conditions: Autistic Disorder;   Asperger Syndrome;   Mental Retardation;   Child;   Adult
Intervention:
4 Recruiting A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With Autism
Condition: Autism Spectrum Disorders
Interventions: Drug: Donepezil;   Drug: Placebo
5 Recruiting A Study of the Association Between Autism and Immune Changes in the Brain
Conditions: Autism Spectrum Disorders;   Brain Disease;   Autism;   Healthy Volunteers
Intervention:
6 Recruiting Near Infrared Spectroscopy in Children With Autism and ADHD
Conditions: Attention Deficit Disorder With Hyperactivity;   Attention Deficit Disorder;   Attention Deficit Hyperactivity Disorder;   Autism;   Autism Spectrum Disorders
Intervention:
7 Recruiting Study of Toddlers With Language Delay
Conditions: Autism;   Language Acquisition;   Language Development;   Toddlers
Intervention:
8 Recruiting Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders
Conditions: Neurological Disorder;   Autism
Intervention:
9 Recruiting Biomarkers of Developmental Trajectories and Treatment in Autism Spectrum Disorder (ASD)
Condition: Children at Risk for ASD
Interventions: Behavioral: Baby JASPER;   Behavioral: Standard Baby Classroom
10 Recruiting Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Patients With Locally Advanced or Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas;   BRCA1 Mutation Carrier;   BRCA2 Mutation Carrier;   Recurrent Pancreatic Cancer;   Stage III Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: veliparib;   Drug: gemcitabine hydrochloride;   Drug: cisplatin;   Other: laboratory biomarker analysis
11 Recruiting AZD1775, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer
Conditions: Stage IB Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer
Interventions: Drug: WEE1 inhibitor MK-1775;   Drug: cisplatin;   Radiation: external beam radiation therapy;   Radiation: pulsed-dose rate brachytherapy;   Radiation: brachytherapy;   Other: pharmacological study;   Other: laboratory biomarker analysis
12 Recruiting Genetics, Brain Structure and Thinking Skills in Autism
Condition: Autism Spectrum Disorders
Intervention:
13 Recruiting Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IVA Squamous Cell Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVA Verrucous Carcinoma of the Larynx;   Stage IVA Verrucous Carcinoma of the Oral Cavity;   Stage IVB Squamous Cell Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVB Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVB Verrucous Carcinoma of the Larynx;   Stage IVB Verrucous Carcinoma of the Oral Cavity;   Stage IVC Squamous Cell Carcinoma of the Larynx;   Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVC Squamous Cell Carcinoma of the Oropharynx;   Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IVC Verrucous Carcinoma of the Larynx;   Stage IVC Verrucous Carcinoma of the Oral Cavity;   Tongue Cancer
Interventions: Drug: WEE1 inhibitor MK-1775;   Other: placebo;   Drug: cisplatin;   Other: pharmacological study;   Other: laboratory biomarker analysis
14 Recruiting Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Cervical Cancer;   Stage II Vaginal Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Vaginal Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma
Interventions: Drug: triapine;   Drug: cisplatin;   Radiation: external beam radiation therapy;   Radiation: brachytherapy;   Other: laboratory biomarker analysis
15 Recruiting Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-Small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Large Cell Lung Cancer;   Metastatic Carcinoma of Unknown Primary;   Neuroendocrine Carcinoma;   Newly Diagnosed Carcinoma of Unknown Primary;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: veliparib;   Other: placebo;   Drug: etoposide;   Drug: cisplatin;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Other: quality-of-life assessment
16 Recruiting Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Proximal Urethral Cancer;   Recurrent Bladder Cancer;   Recurrent Prostate Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Urethral Cancer;   Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;   Stage IV Bladder Cancer;   Stage IV Prostate Cancer;   Stage IV Urethral Cancer;   Transitional Cell Carcinoma of the Bladder;   Ureter Cancer;   Urethral Cancer Associated With Invasive Bladder Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: cisplatin;   Other: placebo;   Biological: bevacizumab;   Other: laboratory biomarker analysis
17 Recruiting Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Children
Conditions: Autoimmune Disease;   Congenital Adrenal Hyperplasia;   Healthy;   Mental Disorder Diagnosed in Childhood;   Neurologic Manifestations
Intervention:
18 Recruiting Effectiveness of Atomoxetine in Treating ADHD Symptoms in Children and Adolescents With Autism
Condition: Autism
Interventions: Drug: Atomoxetine;   Drug: Placebo
19 Not yet recruiting Collaborative Study Of Neurofeedback Training Of 6-18 Year Olds With Autism
Condition: Autism
Intervention: Behavioral: Neurofeedback training
20 Recruiting Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Condition: Pervasive Development Disorders
Interventions: Drug: methylphenidate;   Other: placebo;   Drug: extended-release guanfacine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years